Hair Relaxer Lawsuit 2026 | Cancer Claims, Settlements & Legal Updates

The Hair Relaxer lawsuit has turned into one of those huge product liability cases in the United States, and, yeah, it’s basically grown to include thousands of women who are alleging that using chemical hair straightening products for a long time led to serious health issues. Plaintiffs say specific hair relaxer products actually raised the chance of uterine cancer, ovarian cancer, endometrial cancer, and a handful of other reproductive injuries.

These Hair Relaxer lawsuit cases have sparked real unease about product safety, ingredient clarity, corporate warnings, and the possible health fallout that can show up after repeated exposure to chemicals that are often present in hair relaxers

What the Hair Relaxer Lawsuit Is About?

The hair relaxer lawsuit is basically about claims that certain chemical hair straightening products raised the risk of uterine cancer, ovarian cancer, endometrial cancer, and some other reproductive health troubles. Plaintiffs say long-term contact with those aggressive chemicals in the products led to serious injuries, and yes, that part is emphasized a lot.

These lawsuits have been brought against several cosmetic and beauty companies. The consumers argue that the manufacturers didn’t give enough caution to users about the possible dangers tied to repeated use of chemical hair relaxers, like not really warning them clearly enough.

A good share of the arguments are supported by scientific studies that look at possible connections between frequent hair relaxer use and higher cancer risks.

Timeline of the Hair Relaxer Litigation

Here are the latest timeline updates in the Hair Relaxer class action and MDL litigation.

April 19, 2026 – New Uterine Cancer Claim Added 

A new plaintiff filed, alleging that chemical hair straightener products caused uterine cancer. The complaint points to several hair relaxer product lines that are tied to Strength of Nature and related labels. 

Read about the Camp Lejeune Water Lawsuit Updates

April 15, 2026 – Discovery Wrangling Over Hairstyle Photos 

A dispute popped up about the photographic material the plaintiffs produced. Defendants pushed for more detailed explanations on the hairstyle photos, plus how long the product use lasted and how those periods worked in context. 

April 8, 2026 – The Court Picks 10 Bellwether Cases, And Narrows Things 

Judge Mary Rowland chose 10 representative bellwether cases for the MDL. The court left out claims involving additional cancers, talc allegations, or other complications, so the testing group for trial would be more straightforward. 

March 26, 2026 – Medical Monitoring Class Actions Were Pursued 

Plaintiffs asked for certification of medical monitoring class actions for people exposed to hair relaxer chemicals, who have not been diagnosed with cancer yet, but could have higher future health risks. 

March 9, 2026 – The Expert Discovery Phase Really Cranked Up 

The MDL went deeper into expert discovery and upcoming Daubert battles about scientific evidence. The court also pushed the parties to line up on undisputed matters like warnings, advertising, and product labeling. 

March 4, 2026 – Discovery Spat About Corporate Witnesses 

Plaintiffs wanted corporate depositions focusing on marketing, warnings, and labeling practices. Meanwhile, the defendants tried to trade live testimony for written stipulations, kind of like a shortcut. 

February 16, 2026 – Former Employee Deposition Dispute 

A legal dispute arose about whether confidentiality agreements improperly restricted questioning during a former employee’s deposition involving internal company matters. 

February 3, 2026 – Bellwether Discovery Keeps Going 

Defendants finished most bellwether plaintiff depositions, but other conflicts kept floating around. That includes disputes over third-party witnesses, discovery deadlines, and the corporate testimony schedule. 

January 6, 2026 – Major Defendants Were Identified 

Big-name defendants connected to brands like Dark & Lovely, ORS Olive Oil, Just for Me, Motions, and other chemical hair relaxer products were identified as key players. 

January 4, 2026 – Settlement Talks Still Seem Kind of Early 

Even though the MDL is moving forward, serious settlement discussions have not really started because there’s no trial date on the calendar yet. Experts think rulings later on scientific evidence could change the settlement pressure a lot, going forward.

November 4, 2025 – More Cases Added to the Hair Relaxer MDL

The number of lawsuits in the Hair Relaxer multidistrict litigation (MDL) continues to rise as new plaintiffs come forward alleging that chemical hair straightening products caused uterine, ovarian, and other hormone-related cancers. This growth underscores the widespread impact of these products and suggests increasing public awareness of potential health risks. The court is expected to focus on consolidating discovery to efficiently manage the expanding docket.

October 2, 2025 – Salon Workers’ Hair Relaxer Claims Strengthen the Litigation

Recent filings have highlighted a growing number of salon workers joining the MDL. These individuals allege long-term occupational exposure to toxic chemicals in hair relaxers, leading to severe reproductive and hormonal conditions. Their inclusion adds a new dimension to the litigation, as workplace exposure claims may further demonstrate that repeated, high-frequency contact with these products poses significant health risks. This development could influence future settlement valuations and the direction of expert testimony.

October 1, 2025 – Total MDL Filings Surpass 10,500 Cases

The Hair Relaxer multidistrict litigation (MDL) surpassed 10,500 active cases, marking a major milestone in the ongoing proceedings. The growing number of plaintiffs reflects the widespread concern over the alleged link between chemical hair relaxers and reproductive cancers. As filings continue to rise, the court is prioritizing coordinated discovery and preparing for upcoming bellwether trials that could shape potential settlement negotiations and future litigation strategy.

September 29, 2025 – Court Removes Plaintiffs Failing to Meet MDL Requirements

The presiding judge dismissed several plaintiffs from the Hair Relaxer MDL who failed to comply with documentation and filing deadlines. This move aims to streamline proceedings and ensure that only valid, fully supported claims remain in the active litigation.

September 18, 2025 – Judge Orders Release of Contested Namaste Communications

On September 18, 2025, the court ordered the disclosure of internal emails from Namaste Laboratories, a key defendant in the Hair Relaxer lawsuit. These documents are expected to shed light on what the company knew about potential health risks tied to its chemical hair straightening products.

September 17, 2025 – Court Sets New Discovery Deadlines and Announces Status Conference

The court established new discovery deadlines for the Hair Relaxer MDL and scheduled an upcoming status conference. The goal is to assess progress, resolve pending disputes, and ensure both sides remain on track for pretrial preparations.

September 11, 2025 – Revised Court Order Establishes Fresh Expert Report Timelines

On September 11, 2025, the judge issued an updated order outlining new deadlines for expert witness reports. This adjustment gives both plaintiffs and defendants additional time to complete expert analyses crucial to proving or contesting the alleged health risks of hair relaxer products.

September 5, 2025 – Sally Beauty Files Lawsuit Against Insurer Over Legal Defense Cost

Sally Beauty initiated a lawsuit against its insurance provider, claiming refusal to cover mounting defense expenses tied to ongoing hair relaxer litigation. The dispute highlights growing tensions between beauty retailers and insurers over liability coverage for product-related lawsuits.

Read about the Batiste Dry Shampoo Cancer Lawsuit Updates

September 4, 2025 – Discovery Challenges and Deposition Delays Involving Avlon Emerge

The court addressed ongoing conflicts with Avlon Industries regarding deposition scheduling and discovery production. These disputes have slowed evidence gathering, prompting the judge to remind all parties of their obligations to cooperate and maintain the MDL’s progress.

September 1, 2025 – Court Announces “Science Day” to Review Expert Medical Findings

The court scheduled a Science Day to allow experts to present medical and toxicological evidence regarding chemical exposure from hair relaxers. The session aims to educate the court on scientific links between product ingredients and alleged cancer and hormonal health risks.

August 23, 2025 – Several Plaintiffs Dismissed for Missing Filing Deadlines

Several plaintiffs were removed from the Hair Relaxer MDL after failing to meet court-imposed filing deadlines. The judge emphasized that timely submissions are essential for maintaining fairness and efficiency in the proceedings as the litigation continues to grow in size and complexity.

August 17, 2025 – New Connecticut Plaintiff Joins the Hair Relaxer MDL

A Connecticut resident joined the expanding Hair Relaxer MDL, adding to the growing list of nationwide plaintiffs. The case highlights increasing recognition of the potential link between chemical hair relaxers and cancers such as uterine and ovarian, reinforcing the lawsuit’s national reach.

August 3, 2025 – Ongoing Growth in Hair Relaxer Litigation Numbers

The Hair Relaxer MDL continued its steady rise in case numbers through August 2025. The increase in filings shows mounting public awareness and legal action against manufacturers accused of failing to warn consumers about the cancer risks associated with prolonged hair relaxer use.

July 22, 2025 – Settlement Progress Slows Despite Discovery Momentum

Although discovery efforts in the Hair Relaxer MDL continued to move forward with steady progress, settlement discussions appeared to have slowed. Both plaintiffs and defendants are focusing on building stronger scientific evidence before entering serious negotiations on compensation and liability terms.

June 23, 2025 – Pennsylvania Court Consolidates Hair Relaxer Lawsuits

A Pennsylvania court ordered the consolidation of multiple state-level Hair Relaxer lawsuits to streamline pretrial proceedings. This move aims to reduce duplicative efforts, improve efficiency, and ensure consistent rulings as more plaintiffs across the country file similar product liability and negligence claims.

June 22, 2025 – Georgia Court Considers Time Limits on Long-Term Exposure Claims

A Georgia court reviewed potential time-bar issues concerning plaintiffs who used chemical hair relaxers decades ago. The debate centers on whether the statute of limitations should begin from the time of diagnosis, given the delayed discovery of cancer links to these products.

June 20, 2025 – Court Prepares for First Hair Relaxer Bellwether Trials

The Hair Relaxer Lawsuit MDL reached a crucial stage as preparations began for the initial bellwether trials. Judge Mary M. Rowland’s case management order laid out the framework for selecting representative cases that will go before juries, offering an early test of how evidence and expert testimony may influence future settlements and verdicts.

For many plaintiffs, this moment marks tangible progress in holding manufacturers accountable for alleged links between chemical hair relaxers and reproductive cancers such as uterine, ovarian, and endometrial cancers. The court’s structured timeline ensures that discovery, expert reviews, and motions move forward efficiently over the next two years.

Key Timeline for Bellwether Preparation

June 15, 2025 – Professional Stylists’ Exposure Cases Gain Legal Weight

Recent developments highlight growing attention toward salon professionals regularly exposed to hair relaxer chemicals. Many stylists allege long-term contact caused hormonal and reproductive health problems. The court has begun treating these occupational exposure claims as a significant part of the litigation, expanding beyond individual consumer use. Legal teams are now gathering evidence to demonstrate that daily professional exposure carries a higher cumulative risk, strengthening these plaintiffs’ positions for future settlements and trial consideration.

June 2, 2025 – Philadelphia Hair Relaxer Cases Move Ahead in State Court

Hair relaxer lawsuits filed in Pennsylvania’s state courts are advancing alongside the federal MDL. The Philadelphia Court of Common Pleas has begun coordinating its growing docket of cases to align with national discovery progress. This ensures consistent handling of expert testimony and scientific evidence across jurisdictions. Plaintiffs in these state cases echo the same core allegations—failure to warn, negligence, and product defect—while attorneys anticipate potential bellwether-style trials at the state level later in the litigation timeline.

April 30, 2025 – Settlement Negotiator Appointed to Facilitate Talks

The court has appointed an experienced settlement negotiator to oversee discussions between plaintiffs and the defendants in the Hair Relaxer Lawsuit. This move signals a stronger push toward potential resolution as both sides prepare for bellwether trials. The negotiator’s role is to bridge differences, explore frameworks for compensation, and identify categories of eligible claims. While no settlement offers have been finalized, this appointment marks a significant step toward structured negotiations that could determine future payout ranges.

Read about the OGX Hair Loss Lawsuits

February 11, 2025 – Settlement Discussions Begin to Take Shape

Early settlement talks are now underway in the Hair Relaxer multidistrict litigation. Plaintiffs’ attorneys and defense counsel have begun outlining the scope of potential compensation models, considering medical evidence, exposure levels, and cancer types. Although still preliminary, these discussions indicate openness to resolving a portion of the thousands of pending claims outside of trial. Legal observers suggest that progress at this stage could influence the tone of future bellwether trials and overall negotiation momentum throughout 2025.

February 2, 2025 – Judge Outlines Bellwether Trial Schedule for MDL

Judge Mary M. Rowland has released an updated and comprehensive timeline for the upcoming bellwether trials in the Hair Relaxer multidistrict litigation (MDL). The order sets out firm milestones that will shape how the first test cases move forward, determining which lawsuits will be tried first and when expert evidence will be heard.

The outlined schedule reflects the court’s intent to balance efficiency with fairness while ensuring both sides have ample opportunity to complete discovery. These bellwether cases will help gauge jury reactions and guide potential settlements in the broader litigation involving thousands of women alleging that chemical hair relaxers caused reproductive cancers.

Although the first MDL trial is not expected before 2027, related state court trials may begin earlier. If those state verdicts result in major awards, they could pressure defendants such as L’Oréal and other cosmetic companies to reach national settlements sooner.

Hair Relaxer MDL Bellwether Trial Schedule

Key Takeaways from the Court’s Order

• Expanded Bellwether Pool: The judge increased the number of discovery cases from 16 to 40 to ensure broader representation. Up to 12 of these will advance to trial.
• Eligibility Requirements: Only plaintiffs with uterine, endometrial, or ovarian cancer who filed and served short-form complaints by February 1, 2024, qualify for bellwether selection. Around 5,200 cases meet this standard.
• Selection Process: Both sides will choose 20 cases each, with no extensions beyond the April 30, 2025, deadline.
• Parallel Discovery: The court allows general and case-specific expert discovery to proceed simultaneously to maintain progress.
• Case Substitution Rule: If any discovery case settles before trial selection, plaintiffs may replace it with another eligible case without court approval.

This order demonstrates the court’s determination to move the MDL toward trial readiness while ensuring a fair and balanced review of the scientific and factual evidence central to the Hair Relaxer litigation.

Read about the Batiste Dry Shampoo Cancer Lawsuit Updates

December 4, 2024 – MDL Committee Establishes Common Benefit Fee Structure

The leadership committee overseeing the Hair Relaxer multidistrict litigation (MDL) finalized a plan for a common benefit fund, ensuring that all plaintiffs’ attorneys contributing to shared discovery, expert research, and trial preparation are fairly compensated. This fee structure applies to both federal and state cases that benefit from MDL efforts.

The order outlines a percentage deduction from future settlements or verdicts to fund coordinated work such as expert development, document review, and deposition management. The system is designed to promote collaboration and prevent duplicative efforts while maintaining fairness for all involved firms.

This development marks a critical administrative step toward efficiently managing thousands of claims and ensuring that resources are appropriately distributed when settlements begin.

November 5, 2024 – Uterine Fibroid Lawsuits Regain Focus and Momentum

As scientific attention expands beyond uterine and ovarian cancer, uterine fibroid-related lawsuits are gaining renewed prominence within the Hair Relaxer MDL. Recent medical studies and expert analyses suggest that long-term exposure to certain chemical relaxers may contribute to non-cancerous reproductive issues such as fibroids and hormonal disruptions.

Plaintiffs’ attorneys are now working to highlight these injuries in discovery, seeking to ensure that compensation frameworks reflect both cancer and non-cancer harms. The court’s willingness to consider these additional injury categories could expand the MDL’s scope and lead to a broader, more inclusive settlement structure in the future.

This renewed focus underscores the evolving nature of the litigation as more evidence links chemical hair straighteners to a spectrum of reproductive health conditions.

October 24, 2024 – Overview of Ongoing Hair Relaxer Cases in State Courts

While much of the national focus remains on the federal Hair Relaxer MDL, several state court lawsuits are developing on their own tracks across the U.S. and internationally, with many showing steady progress toward resolution or trial scheduling.

• Cook County, Illinois: Fifty-seven hair relaxer lawsuits have been filed, with forty-four already consolidated before Judge Patrick T. Stanton for coordinated motion practice and discovery. Briefing on dismissal motions for four bellwether cases is complete, and rulings are pending. Discovery remains paused until these decisions are issued. Five cases could head to trial by late 2025 or early 2026, while thirteen others await consolidation following an August 28 hearing.
• Georgia: Twenty cases have been grouped in Chatham County under Judge Derek J. White, though proceedings are temporarily stayed due to an appeal in Burroughs v. L’Oréal USA, Inc., which centers on a statute of repose issue. Another seven cases are active in DeKalb County, with consolidation requests before Judge Alvin T. Wong.
• New York: Two cases in New York County are awaiting rulings on motions to dismiss.
• Pennsylvania: Six cases are ongoing in Philadelphia’s Court of Common Pleas, where plaintiffs and defendants are briefing and pleading challenges. The Pennsylvania docket is expected to grow substantially as more claims are filed and consolidated.
• Canada: Two class action lawsuits have been initiated, but neither has yet advanced to a class certification stage.

Read about the Talcum Powder Lawsuit

Who Can Join the Hair Relaxer Lawsuit and How to File?

Individuals who developed uterine cancer, ovarian cancer, endometriosis, or other hormone-related conditions after long-term use of chemical hair relaxers may qualify to join the hair relaxer lawsuit. The products most commonly cited include those made by L’Oréal, Revlon, SoftSheen-Carson, and Strength of Nature, among others.

To be eligible, plaintiffs should have:

• A confirmed medical diagnosis linked to relaxer use.
• A history of consistent use of chemical relaxers over several years.
• Proof of purchase, product use, or brand identification.

To file, individuals typically contact an attorney handling hair relaxer cancer lawsuits. The attorney will review medical records and usage history and determine eligibility to join the ongoing multidistrict litigation (MDL) currently centralized in the Northern District of Illinois.

Conclusion

The ongoing Hair Relaxer lawsuit keeps growing, as more people come forward claiming injuries tied to chemical hair straightening products. Right now, courts are reviewing scientific findings, corporate behavior, and bellwether matters, which could end up steering later settlement talks and verdict outcomes. The plaintiffs are asking for compensation for medical costs, emotional strain, lost earnings, and other harms that relate to what they say their diagnoses have caused. The Hair Relaxer lawsuit cases may also nudge future cosmetic safety standards, and yeah, they are boosting public awareness about the possible dangers connected with long-term hair relaxer use.

Read about the Zantac Lawsuit Updates

Frequently Asked Questions on Hair Relaxer Lawsuit